139059-02-2Relevant articles and documents
TETRAZOLE COMPOUNDS AS OREXIN RECEPTOR ANTAGONISTS
-
Page/Page column 28, (2011/04/25)
The invention relates to tetrazole compounds of formula (I) wherein X, Y, Z, R1, R2 and R3 are as described in the description; to pharmaceutically acceptable salts thereof, and to the use of such compounds use as medicaments, especially as orexin receptor antagonists.
Tetrazole thioacetanilides: Potent non-nucleoside inhibitors of WT HIV reverse transcriptase and its K103N mutant
Muraglia, Ester,Kinzel, Olaf D.,Laufer, Ralph,Miller, Michael D.,Moyer, Gregory,Munshi, Vandna,Orvieto, Federica,Palumbi, Maria Cecilia,Pescatore, Giovanna,Rowley, Michael,Williams, Peter D.,Summa, Vincenzo
, p. 2748 - 2752 (2007/10/03)
A series of aryltetrazolylacetanilides was synthesized and evaluated as HIV-1 non-nucleoside reverse transcriptase inhibitors on wild-type virus and on the clinically relevant K103N mutant strain. Extensive SAR investigation led to potent compounds, with nanomolar activity on K103N, and orally bioavailable in rats.